Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
08/31/14 Regeneron (REGN) Alirocumab for Dyslipidemia / Hypercholesterolemia Subscribers Only Subscribers Only     Subscribers Only
08/31/14 Novartis (NVS) LCZ696 for Congestive Heart Failure (CHF) Subscribers Only Subscribers Only     Subscribers Only
08/28/14 Pfizer (PFE) PF-06425090 for Clostridium difficile-Associated Diarrhea/Infection (CDAD/CDI) Subscribers Only Subscribers Only     Subscribers Only
08/28/14 Amgen (AMGN) Evolocumab for Dyslipidemia / Hypercholesterolemia Subscribers Only Subscribers Only     Subscribers Only
08/28/14 OncoMed Pharmaceuticals (OMED) Vantictumab for Non-Small Cell Lung Cancer (NSCLC) Subscribers Only Subscribers Only     Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
08/31/14 Subscribers Only Subscribers Only Partnership - Acquisition Completion
08/31/14 Subscribers Only Subscribers Only Partnership - Acquisition Completion
08/31/14 Subscribers Only Subscribers Only Trial Data - Updated Results
08/31/14 Subscribers Only Subscribers Only Trial Data - Updated Results
08/31/14 Subscribers Only Subscribers Only Trial Data - Top-Line Results